Forge Resources Corp. announced successful drilling results from its 2026 program at the Alotta Project in Yukon, Canada, where six holes totaling 2,792 meters were drilled. The deepest hole reached 651 meters and showed continuous mineralization and alteration, indicating multiple porphyry centers rather than a single deposit. Visible gold was found in the Payoff Zone, supporting the presence of a large, complex gold system. Assay results are pending, and the company plans to further analyze the multi-center system to advance exploration efforts.
Forge Resources' drilling results at Alotta provide context for readers following mining developments. For readers following Basic Materials sector stocks on Pluang as of Sep 15, 2026 21:43 WIB, 10 of 32 priced US stocks rose while 22 fell. Among these, Agnico Eagle Mines Ltd (AEM) traded at USD 194.40 with a 1-day decline of 1.59%, Kinross Gold Corporation (KGC) at USD 27.78 down 1.42%, and Albemarle Corp. (ALB) at USD 113.43 down 1.39%.
Kering has released its monthly statement detailing the total number of shares and voting rights as of October 15, 2026. The company reported 123,420,778 total shares and 176,815,752 theoretical voting rights, with 176,046,302 exercisable voting righ...
Kering published its monthly update on October 15, 2026, reporting a total of 123,420,778 shares composing its capital and 176,815,752 theoretical voting rights. The voting rights figure includes all shares with voting rights, including those tempora...
Pepeto, a new cryptocurrency on the Ethereum network, has quickly raised over $11.23 million in its presale, with each funding stage closing faster than the last. This momentum comes as Ethereum is predicted to reach $10,000 by the end of 2026, drive...
Opus Genetics announced FDA approval of phentolamine ophthalmic solution 0.75% for treating presbyopia, an age-related condition affecting near vision in adults. This approval, based on successful Phase 3 trials, provides a non-invasive option that i...
BlackRock, Inc. disclosed that its voting rights in pharmaceutical company Fagron NV fell below the 3% reporting threshold due to the transfer of voting securities, despite acquiring financial instruments equivalent to voting rights. As of October 12...
